SMBC Nikko downgraded Jounce Therapeutics to Neutral from Outperform.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on JNCE:
- Jounce, Redx Pharma announce recommended all share merger transaction
- Jounce downgraded to Market Perform from Outperform at Raymond James
- Redx and Jounce Announce Recommended Business Combination
- Jounce Therapeutics Announces Restructuring
- Jounce Therapeutics to reduce workforce by 57%
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue